ArticlePharmaceutical research2026

Central Composite Design-Optimized Dabigatran Etexilate Cubosomes for Sustained Oral Release and Enhanced In Vivo Pharmacokinetics.

Aashka H Bhatt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.